Scholars Central

Conference abstractPublished 4 Sep 2017

Effect of anakinra on cirrhotic cardiomyopathic rats

Authors: Aya Y Gawish, Hebatalla I Ahmed, Medhat I Abd El-Hamid, Azza A Ali

Sinai University, Egypt; Al-Azhar University (Girls), Egypt; Al-Azhar University (Boys), Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Cirrhotic cardiomyopathy (CCM) is a chronic cardiac dysfunction in cirrhotic patients. It is characterized by hyper dynamic circulation from the peripheral vasodilatation imposed by the neuroendocrine imbalance of hepatic cirrhosis, with increased cardiac output at rest, decreased peripheral vascular resistance and altered diastolic relaxation with electrophysiological abnormalities. The electrical abnormalities include elongation in the QT intervals. Interleukin-1 beta (IL-1 Ã?²) is an important proinflammatory cytokine; both IL-1Ã?² and tumor necrosis factor Ã?± (TNFÃ?±) exerted a negative inotropic effect in control papillary muscles through an NO-dependent mechanism, leading to NO production, which played an important role in the pathogenesis of CCM. Aim: Aim of this study is to examine the curative and prophylactic effect of IL-1Ã?² blocker (anakinra) on CCM in rats. Methods: CCM was induced by bile duct ligation (BDL) in rats, after 23 days cirrhosis was demonstrated by histopathological studies and serum alkaline phosphatase (ALP), alanine transferase (ALT), aspartate transferase (AST) and cardiomyopathy was confirmed by electrocardiograph, serum brain natriuretic (BNP), glutathione transferase (GSTs), TNFÃ?± and tissue cardiac troponin I (cTnI). Anakinra was administered to curative group in day 24 of BDL for five daily doses and it was administered to prophylactic group from day 1 of BDL for 28 daily doses. The data were analyzed by one way ANOVA. Results: After 23 days, serum ALP, AST, ALT, BNP, GSTs, TNFÃ?±, tissue cTnI were increased and prolonged QT intervals occurred. After 28 days, in comparison to control CCM group, the curative group 10 mg/kg dose of anakinra significantly decreased in serum ALP, AST, ALT, BNP, GSTs, TNFÃ?±, tissue cTnI (p<0.005) and in the prophylactic group 10 mg/kg dose of anakinra, they showed significant decrease (p<0.005), and the restoration of QT intervals occurred in both groups. Conclusion: Targeted blocker of IL-1 Ã?² may prove beneficial for reduction and prophylaxis of CCM.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Biochemistry & Pharmacology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Aya Y Gawish”
  • BylineArticles whose byline prints “Hebatalla I Ahmed”
  • BylineArticles whose byline prints “Medhat I Abd El-Hamid”
  • BylineArticles whose byline prints “Azza A Ali”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels